To determine whether FLT3L could up-regulate CD1c+DCs in vitro, SLE PBMCs were stimulated with different concentrations of recombinant human FLT3L (1, 10, 100 and 500 ng/ml). This evidence concerns the gene FLT3LG and systemic lupus erythematosus.